Eli Lilly is planning to build a $3.5 billion life sciences plant in Pennsylvania's Lehigh Valley. The facility is expected to be used for manufacturing, with some reports indicating it will produce injectable medicines and devices, while others specify weight-loss drugs. The project is slated to begin in 2026, although details about the facility's exact purpose and timeline are not uniformly reported.